PILL.CN - Canntab Therapeutics Limited

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 516.7M
Enterprise Value 314.27M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)246.43
Price/Book (mrq)6.23
Enterprise Value/Revenue 3210.60
Enterprise Value/EBITDA 6-5.64

Trading Information

Stock Price History

Beta (3Y Monthly) -2.56
52-Week Change 311.11%
S&P500 52-Week Change 38.16%
52 Week High 32.1400
52 Week Low 30.6000
50-Day Moving Average 30.7192
200-Day Moving Average 30.8284

Share Statistics

Avg Vol (3 month) 332.22k
Avg Vol (10 day) 310.76k
Shares Outstanding 525.31M
Float 17.31M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (May 15, 2019) 46.42k
Short Ratio (May 15, 2019) 40.17
Short % of Float (May 15, 2019) 4N/A
Short % of Shares Outstanding (May 15, 2019) 40.03%
Shares Short (prior month Apr 15, 2019) 4391

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Mar 8, 2016
Last Split Factor (new per old) 2200/1
Last Split Date 3Apr 20, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends May 31, 2018
Most Recent Quarter (mrq)Feb 28, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-3,854.69%

Management Effectiveness

Return on Assets (ttm)-87.91%
Return on Equity (ttm)-239.56%

Income Statement

Revenue (ttm)67.78k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)170.00%
Gross Profit (ttm)26.67k
EBITDA -2.53M
Net Income Avi to Common (ttm)-3.57M
Diluted EPS (ttm)-0.1380
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.43M
Total Cash Per Share (mrq)0.1
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)11.35
Book Value Per Share (mrq)0.11

Cash Flow Statement

Operating Cash Flow (ttm)-2.27M
Levered Free Cash Flow (ttm)-1.32M